ClinicalTrials.Veeva

Menu

Prevalence of Thyroid Dysfunction and Anti-thyroid Antibodies in Infertile Women

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Infertility, Female

Treatments

Diagnostic Test: Antibody assay
Diagnostic Test: Hormonal assay

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The study population will be divided into three groups:

  • Group (A) consisting of 40 infertile women with either unexplained or anovulatory infertility with/without associated male factor of infertility,

  • Group (B) consisting of 40 infertile women with tubal (mechanical) factor of infertility with/without associated male factor of infertility, and

  • Group (C) consisting of 40 women with exclusive male factor of infertility and will be used as a control group.

    . All women will be subjected to:

  • Informed consent

  • Full history taking, including age, duration of infertility and whether primary or secondary

  • General and pelvix examination

  • Trans-vaginal ultrasonography

  • Determination of hormonal profile (FSH, LH, Estradiol, Prolactin)

  • Determination of ovulatory status

  • Determination of of tubal patency

  • Determination of presence of male factor

  • Determination of TSH and antithyroid antibodies (antithyroglobulin and antithyroid peroxidase) blood levels

Full description

The study population will be divided into three groups:

  • Group (A) consisting of 40 infertile women with either unexplained or anovulatory infertility with/without associated male factor of infertility,

  • Group (B) consisting of 40 infertile women with tubal (mechanical) factor of infertility with/without associated male factor of infertility, and

  • Group (C) consisting of 40 women with exclusive male factor of infertility and will be used as a control group.

    . All women will be subjected to:

  • Informed consent

  • Full history taking, including age, duration of infertility and whether primary or secondary

  • General and pelvix examination

  • Trans-vaginal ultrasonography

  • Determination of hormonal profile (FSH, LH, Estradiol, Prolactin)

  • Determination of ovulatory status (by previous documented history of induction of ovulation OR previous ultrasonography OR previous estimation midluteal serum progesterone, etc ...)

  • Determination of of tubal patency (by previous hysterosalpingiography or laparoscopy)

  • Determination of presence of male factor (by seminal fluid analysis)

  • Determination of TSH and antithyroid antibodies (antithyroglobulin and antithyroid peroxidase) blood levels

Enrollment

120 estimated patients

Sex

Female

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    • Age: 18 - 38 years
  • Infertile women whether due to functional, anatomical, male factors OR unexplained OR combined factors

Exclusion criteria

    • Age: below 18 and above 38 years
  • Patients with autoimmune diseases (such as lupus and rheumatoid arthritis)
  • Acute illness that require hospitalization
  • Patients on the following medications: steroids, dopamine, iodine, amiodarone, lithium, donperidone, thyroid hormone, and phenytoin.
  • Patients who work at night.

Trial design

120 participants in 3 patient groups

Anovulatory women
Description:
40 infertile women with either unexplained or anovulatory infertility with/without associated male factor of infertility
Treatment:
Diagnostic Test: Hormonal assay
Diagnostic Test: Antibody assay
Tubal factor women
Description:
40 infertile women with tubal (mechanical) factor of infertility with/without associated male factor of infertility
Treatment:
Diagnostic Test: Hormonal assay
Diagnostic Test: Antibody assay
male factor couple
Description:
40 women with exclusive male factor of infertility and will be used as a control group
Treatment:
Diagnostic Test: Hormonal assay
Diagnostic Test: Antibody assay

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed Maged; Ahmed wali

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems